Anti-TrkA (phospho Y674)+TrkB (phospho Y706)+TrkC (phospho Y709) antibody [EPR22298-67]
- RabMAb
- Recombinant
- 20ul selling size
- What is this?
Be the first to review this product! Submit a review
|
(31 Publications)
Anti-TrkA (phospho Y674) + TrkB (phospho Y706) + TrkC (phospho Y709) antibody [EPR22298-67] (ab229908) is a rabbit monoclonal antibody detecting TrkA in Western Blot, Dot Blot. Suitable for Human, Mouse, Rat.
- Biophysical QC for unrivalled batch-batch consistency
- Over 10 publications
View Alternative Names
TRKB, NTRK2, BDNF/NT-3 growth factors receptor, GP145-TrkB, Neurotrophic tyrosine kinase receptor type 2, TrkB tyrosine kinase, Tropomyosin-related kinase B, Trk-B
- WB
Unknown
Western blot - Anti-TrkA (phospho Y674)+TrkB (phospho Y706)+TrkC (phospho Y709) antibody [EPR22298-67] (AB229908)
Blocking/Diluting buffer and concentration : 5% NFDM/TBST
Observed MW : 140 kDA
All lanes:
Western blot - Anti-TrkA (phospho Y674)+TrkB (phospho Y706)+TrkC (phospho Y709) antibody [EPR22298-67] (ab229908) at 1/1000 dilution
Lane 1:
Human brain at 20 µg
Lane 2:
Human Hippocampus at 20 µg
Lane 3:
Human cerebellum at 20 µg
Lane 4:
Human spinal cord at 20 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG (HRP) with minimal cross-reactivity with human IgG at 1/2000 dilution
Predicted band size: 92 kDa
false
Exposure time: 5s
- WB
Lab
Western blot - Anti-TrkA (phospho Y674)+TrkB (phospho Y706)+TrkC (phospho Y709) antibody [EPR22298-67] (AB229908)
Blocking buffer and dilution concentration : 5% NFDM/TBST.
Lanes 1 - 4:
Western blot - Anti-TrkA (phospho Y674)+TrkB (phospho Y706)+TrkC (phospho Y709) antibody [EPR22298-67] (ab229908) at 1/1000 dilution
Lanes 1 - 4:
Western blot - Anti-TrkA (pY674) + TrkB (pY706) + TrkC (pY709) antibody [EPR22298-67] - BSA and Azide free (<a href='/en-us/products/primary-antibodies/trka-phospho-y674trkb-phospho-y706trkc-phospho-y709-antibody-epr22298-67-bsa-and-azide-free-ab264070'>ab264070</a>) at 1/1000 dilution
Lane 1:
293T (human embryonic kidney epithelial cell) cells transfected with an empty vector containing a His-tag, whole cell lysate at 20 µg
Lane 2:
293T cells transfected with a human TrkA expression vector containing a His-tag, whole cell lysate at 20 µg
Lane 3:
293T cells transfected with a human TrkB expression vector containing a His-tag, whole cell lysate at 20 µg
Lane 4:
293T cells transfected with a human TrkC expression vector containing a His-tag, whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Observed band size: 140 kDa
false
Exposure time: 15s
- WB
Lab
Western blot - Anti-TrkA (phospho Y674)+TrkB (phospho Y706)+TrkC (phospho Y709) antibody [EPR22298-67] (AB229908)
Blocking and diluting buffer and concentration : 5% NFDM/TBST
The expression profile/ molecular weight observed is consistent with what has been described in the literature (PMID : 24959744). Besides, TrkB auto-phosphorylation was observed when TrkB was over-expressed in HEK293 cells, which has been reported in the literature (PMID : 25632160).
Exposure time : 7 seconds
All lanes:
Western blot - Anti-TrkA (phospho Y674)+TrkB (phospho Y706)+TrkC (phospho Y709) antibody [EPR22298-67] (ab229908) at 1/5000 dilution
Lane 1:
HEK-293T (human embryonic kidney) transfected with an empty vector (vector control), containing a myc-His-tag®, whole cell lysate at 10 µg
Lane 2:
HEK-293T transfected with human TrkB (WT) expression vector containing a myc-His-tag®, whole cell lysate (Untreated membrane) at 10 µg
Lane 3:
HEK-293T transfected with human TrkB (WT) expression vector containing a myc-His-tag®, whole cell lysate (Phosphatase treated membrane) at 10 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/50000 dilution
Predicted band size: 92 kDa
Observed band size: 140 kDa
false
- WB
Unknown
Western blot - Anti-TrkA (phospho Y674)+TrkB (phospho Y706)+TrkC (phospho Y709) antibody [EPR22298-67] (AB229908)
Blocking/Diluting buffer and concentration : 5% NFDM/TBST
Observed MW : 140 kDA
All lanes:
Western blot - Anti-TrkA (phospho Y674)+TrkB (phospho Y706)+TrkC (phospho Y709) antibody [EPR22298-67] (ab229908) at 1/1000 dilution
Lane 1:
Mouse brain lysates at 20 µg
Lane 2:
Mouse hippocampus at 20 µg
Lane 3:
Mouse P7 thalamus at 20 µg
Lane 4:
Mouse cerebellum at 20 µg
Lane 5:
Rat brain at 20 µg
Lane 6:
Rat hippocampus at 20 µg
Lane 7:
Rat P7 thalamus at 20 µg
Lane 8:
Rat cerebellum at 20 µg
Lane 9:
Mouse P5 cerebral cortex at 20 µg
Lane 10:
Mouse P3 retina at 20 µg
Lane 11:
Mouse P20 retina at 20 µg
Lane 12:
Rat spinal cord at 20 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Predicted band size: 92 kDa
false
Exposure time: 180s
- WB
Lab
Western blot - Anti-TrkA (phospho Y674)+TrkB (phospho Y706)+TrkC (phospho Y709) antibody [EPR22298-67] (AB229908)
Blocking and diluting buffer and concentration : 5% NFDM/TBST
The phosphorylation sites are conserved between TrkA and TrkB : Tyr674/675 of TrkA corresponds to Tyr706/707 in TrkB. Therefore, the TrkB (phospho T705) antibody can detect the phosphorylation of TrkA T674/675 in PC-12 cells treated with NGF. The expression profile/ molecular weight observed is consistent with what has been described in the literature (PMID : 23951412).
Exposure time : 3 minutes
All lanes:
Western blot - Anti-TrkA (phospho Y674)+TrkB (phospho Y706)+TrkC (phospho Y709) antibody [EPR22298-67] (ab229908) at 1/1000 dilution
Lane 1:
Untreated PC-12 (rat adrenal gland pheochromocytoma), whole cell lysate at 10 µg
Lane 2:
PC-12 treated with 100ng/ml NGF (<a href='/en-us/products/proteins-peptides/recombinant-human-ngf-protein-active-ab9796'>ab9796</a>) for 5 minutes at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/50000 dilution
Predicted band size: 92 kDa
Observed band size: 140 kDa
false
- WB
Lab
Western blot - Anti-TrkA (phospho Y674)+TrkB (phospho Y706)+TrkC (phospho Y709) antibody [EPR22298-67] (AB229908)
Blocking and diluting buffer and concentration : 5% NFDM/TBST
The expression profile/ molecular weight observed is consistent with what has been described in the literature (PMID : 24959744). Besides, TrkB auto-phosphorylation was observed when TrkB was over-expressed in HEK293 cells, which has been reported in the literature (PMID : 25632160).
Exposure time : 48 seconds
All lanes:
Western blot - Anti-TrkA (phospho Y674)+TrkB (phospho Y706)+TrkC (phospho Y709) antibody [EPR22298-67] (ab229908) at 1/5000 dilution
Lane 1:
HEK-293T (human embryonic kidney) transfected with an empty vector (vector control), containing a myc-His-tag®, whole cell lysate at 10 µg
Lane 2:
HEK-293T transfected with mouse TrkB (WT) expression vector containing a myc-His-tag®, starved for 6 hours, whole cell lysate at 10 µg
Lane 3:
HEK-293T transfected with mouse TrkB (WT) expression vector containing a myc-His-tag®, starved for 6 hours, then treated with 50ng/ml BDNF (<a href='/en-us/products/proteins-peptides/recombinant-human-murine-rat-bdnf-protein-active-ab9794'>ab9794</a>) for 10 minutes, whole cell lysate (Untreated membrane) at 10 µg
Lane 4:
HEK-293T transfected with mouse TrkB (WT) expression vector containing a myc-His-tag®, starved for 6 hours, then treated with 50ng/ml BDNF (<a href='/en-us/products/proteins-peptides/recombinant-human-murine-rat-bdnf-protein-active-ab9794'>ab9794</a>) for 10 minutes, whole cell lysate (Phosphatase treated membrane) at 10 µg
Lane 5:
HEK-293T transfected with mouse TrkB (mutant Y705A) expression vector containing a myc-His-tag®, whole cell lysate at 10 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/50000 dilution
Predicted band size: 92 kDa
Observed band size: 140 kDa
false
- WB
Lab
Western blot - Anti-TrkA (phospho Y674)+TrkB (phospho Y706)+TrkC (phospho Y709) antibody [EPR22298-67] (AB229908)
Blocking and diluting buffer and concentration : 5% NFDM/TBST
ab181602 was used as a GAPDH loading control at 1/200000 dilution.
All lanes:
Western blot - Anti-TrkA (phospho Y674)+TrkB (phospho Y706)+TrkC (phospho Y709) antibody [EPR22298-67] (ab229908) at 1/1000 dilution
Lane 1:
293T (human embryonic kidney epithelial cell) cells transfected with an empty vector containing a His-tag, whole cell lysate at 20 µg
Lane 2:
293T cells transfected with a human TrkA expression vector containing a His-tag, whole cell lysate at 20 µg
Lane 3:
293T cells transfected with a human TrkB expression vector containing a His-tag, whole cell lysate at 20 µg
Lane 4:
293T cells transfected with a human TrkC expression vector containing a His-tag, whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Observed band size: 95 kDa,140 kDa
false
Exposure time: 15s
- Dot
Unknown
Dot Blot - Anti-TrkA (phospho Y674)+TrkB (phospho Y706)+TrkC (phospho Y709) antibody [EPR22298-67] (AB229908)
Dot blot analysis using ab229908 at 1/1000 dilution, followed by a Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated (ab97051) at 1/100,000 dilution.
Lane 1 : TrkB (phospho T705) peptide (aa697-708)
Lane 2 : TrkB (phospho T705) peptide (aa702-712)
Lane 3 : TrkB non-phospho peptide (aa697-712)
Blocking/diluting buffer and concentration : 5% NFDM/TBST
- Dot
Lab
Dot Blot - Anti-TrkA (phospho Y674)+TrkB (phospho Y706)+TrkC (phospho Y709) antibody [EPR22298-67] (AB229908)
Blocking and diluting buffer and concentration : 5% NFDM/TBST
All lanes:
Dot Blot - Anti-TrkA (phospho Y674)+TrkB (phospho Y706)+TrkC (phospho Y709) antibody [EPR22298-67] (ab229908) at 1/1000 dilution
Lane 1:
Human TrkA (phospho Y674) peptide
Lane 2:
Human TrkA (phospho Y675) peptide
Lane 3:
Human TrkA (phospho Y674/675) peptide1
Lane 4:
Human TrkA (phospho Y674/675) peptide2
Lane 5:
Human TrkA control peptide for Lane 1-4
Lane 6:
Human TrkB (phospho Y706) peptide
Lane 7:
Human TrkB (phospho Y707) peptide
Lane 8:
Human TrkB (phospho Y706/707) peptide
Lane 9:
Human TrkB control peptide for Lane 6-8
Lane 10:
Human TrkC (phospho Y709) peptide
Lane 11:
Human TrkC (phospho Y710) peptide
Lane 12:
Human TrkC (phospho Y709/710) peptide
Lane 13:
Human TrkC control peptide for Lane 10-12
Secondary
All lanes:
Dot Blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
false
Exposure time: 180s
Related conjugates and formulations (1)
-
Anti-TrkA (pY674) + TrkB (pY706) + TrkC (pY709) antibody [EPR22298-67] - BSA and Azide free
Reactivity data
Product details
What is this antibody validated in?
Anti-TrkA (phospho Y674) + TrkB (phospho Y706) + TrkC (phospho Y709) antibody [EPR22298-67] (ab229908) is a rabbit recombinant monoclonal antibody and is validated for use in Western Blot (WB), Dot Blot in Human, Mouse, Rat samples.
What is the molecular weight of TrkA?
Anti-TrkA (phospho Y674) + TrkB (phospho Y706) + TrkC (phospho Y709) antibody [EPR22298-67] (ab229908) specifically detects a band for TrkA (UniProt: Q16288) at a molecular weight of 92kDa.
Trusted by the scientific community
Anti-TrkA (phospho Y674) + TrkB (phospho Y706) + TrkC (phospho Y709) antibody [EPR22298-67] (ab229908) was first used in a scientific publication in 2019 and has been cited over 10 times in peer-reviewed journals.
Trial sizes available!
Test your antibody or perform pre-screening before committing to a larger quantity. Sold in 10µl. Discover our selection of trial-size antibodies.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
TrkB plays essential roles in neuronal survival differentiation and synaptic plasticity. It acts as an important mediator for the effects of neurotrophins primarily BDNF on neurons. While TrkB itself is not part of a multi-protein complex it interacts closely with several adaptor proteins post-activation to propagate survival and proliferation signals within the neuron. These biochemical interactions greatly influence neurodevelopment and cognitive functions.
Pathways
TrkB is a pivotal player in both the MAPK/ERK and PI3K/AKT pathways. Upon BDNF binding TrkB undergoes autophosphorylation triggering these pathways which are critically involved in cell survival and growth. Other proteins such as SHC1 and PLCγ interact with TrkB in these pathways extending the range of cellular responses to neurotrophin signaling facilitating processes like neuronal plasticity and memory formation.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Additional targets
Publications (31)
Recent publications for all applications. Explore the full list and refine your search
Biomolecules 15: PubMed40867632
2025
Applications
Unspecified application
Species
Unspecified reactive species
Cell reports. Medicine 6:102217 PubMed40834855
2025
Applications
Unspecified application
Species
Unspecified reactive species
Comprehensive Physiology 15:e70031 PubMed40765038
2025
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in pharmacology 16:1592187 PubMed40453656
2025
Applications
Unspecified application
Species
Unspecified reactive species
NPJ precision oncology 9:137 PubMed40348911
2025
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in neuroscience 18:1509543 PubMed39844852
2025
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in pharmacology 15:1422693 PubMed39611170
2024
Applications
Unspecified application
Species
Unspecified reactive species
Biological research 57:87 PubMed39574138
2024
Applications
Unspecified application
Species
Unspecified reactive species
Cell communication and signaling : CCS 22:427 PubMed39223674
2024
Applications
Unspecified application
Species
Unspecified reactive species
Aging 16:6510-6520 PubMed38579169
2024
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com